Get startedLog in
    Picture of Egetis Therapeutics AB (publ) logo

    EGTX — Egetis Therapeutics AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Egetis Granted Rolling NDA Review By FDA For Emcitate®

    Picture of Egetis Therapeutics AB (publ) logoEgetis Therapeutics AB (publ)
    23/10/2025 07:12
    Oct 23 (Reuters) - Egetis Therapeutics AB (publ) EGTX.ST:

EGETIS GRANTED A ROLLING NDA REVIEW BY FDA FOR EMCITATE® (TIRATRICOL) BASED ON CURRENTLY AVAILABLE CLINICAL DATA

Source text: ID:nMFN4CVMd1

Further company coverage: EGTX.ST

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Egetis Therapeutics AB (publ)

    See all news